Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Diabetes
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Health News / SMT announces positive results from the S flex UK Registry

SMT announces positive results from the S flex UK Registry

Ultrathin Sirolimus Eluting Bio absorbable Polymer Coated Stent – The UK Experience

By: Editorial Team   | | Published: January 29, 2018 5:19 pm
Tags: Bio-absorbable stents  Cardiac stents  Stents  
bioabsorbable stents
Stents made in India prove to have better efficacy. © Shutterstock

SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, today announced the successful results of S flex UK Registry. The one-year outcome data of the study was presented at The British Cardiovascular Intervention Society (BCIS), 2018 held in London, UK. The outcome clearly demonstrated the safety and clinical performance of Supraflex, Sirolimus-Eluting Coronary Stent System thereby setting a new benchmark in Indian cardiovascular industry, which is ready to compete with global players. Also Read - Lancet says, Indian made stents safe, effective

Titled as Prospective Evaluation of the Supraflex, Sirolimus-Eluting Coronary Stent System in a ‘Real-World’ Patient Population, the S Flex UK Registry trial was conducted among 469 patients from July 2015 to November 2016. The study was conducted at 11 hospitals in the UK.The Primary endpoints of the study were Target Lesion Failure (TLF) at 12 months (Cardiac death, target vessel MI, or clinically-driven TLR). This real world, all comers, multi-centre UK registry of 469 patients undergoing PCI showed that the Supraflex stent to be safe with a TLF rate of 3.2% with no definite stent thrombosis, potential plus probable stent thrombosis incidence of 0.9% at 360 days. Also Read - Everything you need to know about angioplasty and stent replacement



The principal investigator of the study Dr Azfar Zaman, Professor of Cardiology, Freeman Hospital and Newcastle University, UK said, “The One-year safety and efficacy outcomes clearly highlight the excellent safety profile and excellent deliverability of Supraflex which is essential for PCI procedures. We believe ultrathin 60-micron struts, bio-degradable polymer and proven antiproliferative drug are the intrinsic elements of the superior performance of Supraflex.” Also Read - TALENT study finds that made in India Supraflex stent clinically at par with Abbott's Xience

“We are pleased to be able to report these excellent one-year results, confirming that Supraflex can be considered the new benchmark for DES, beginning of a new era of Ultrathin stents. We are committed to nurturing the meaningful innovations that deliver better patient outcomes. Here we leverage a decade-long healing experience while bringing the best of efficacy and safety outcomes offered through SMT DES.” added Mr CheranUthirapathi, VP International Sales & Marketing, SMT.

Ecstatic about the successful results of S flex UK RegistryMr. Piyush Savalia, Sr. V.P. Marketing & Clinical Trial, SMT said, “Evidence-Based Medicine is at the core of SMT’s product development strategy. Given the consistency with which the Supraflex stent has performed across the wide spectrum of clinical parameters through various other clinical studies, we are upbeat that UK S Flex study has produced positive and excellent clinical outcomes that physicians expect from a next-generation DES”.

Press Release

Image Source: Shutterstock

Published : January 29, 2018 5:19 pm
Read Disclaimer

3 myths about leprosy busted!

3 myths about leprosy busted!

Robotic surgery -- a new hope for the fight against cancer

Robotic surgery -- a new hope for the fight against cancer

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • South African coronavirus variant may 'escape antibodies, cause reinfection'
  • Beware! Coronavirus can damage your brain in many ways. Here’s what to know
  • You are at higher risk to catch Coronavirus in closed spaces. Here’s how
  • Is reinfection of coronavirus a reality? Know if you are at risk
  • COVID-19 vaccines: How It Works, Who Should Take It, Safety, Precautions And Thereafter

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Lancet says, Indian made stents safe, effective

Lancet says, Indian made stents safe, effective

Everything you need to know about angioplasty and stent replacement

Everything you need to know about angioplasty and stent replacement

TALENT study finds that made in India Supraflex stent clinically at par with Abbott's Xience

TALENT study finds that made in India Supraflex stent clinically at par with Abbott's Xience

World’s first DUCTAL Stenting on the smallest baby performed in India

World’s first DUCTAL Stenting on the smallest baby performed in India

New technology that can identify blockages in the heart discovered

New technology that can identify blockages in the heart discovered

Health News in Hindi

Coronavirus Impact on Brain: क्या कोरोना वायरस कर देता है दिमाग को कमज़ोर?, अब साइंटिस्ट करेंगे इस बात की जांच

जवानी में बाल सफेद होने से परेशान हैं तो करी पत्‍ते से करें इसका उपचार, बालों का झड़ना भी हो जाएगा कम

दुबले-पतले शरीर वालों को तंदुरुस्त बना देंगी यह 4 ट्रिक्स, जानिए बॉडी ट्रांसफॉर्म करने के उपाय

Treating Diabetes with Ayurveda: डायबिटीज की बीमारी हो जाएगी खत्म, आज़माएं ये आयुर्वेदिक तरीके

खाना खाने के बाद कभी न करें ये 6 काम, आयुर्वेद में है सख्‍त मनाही, एक्‍सपर्ट से जानिए कारण

Read All

Recent Posts

  • South African coronavirus variant may ‘escape antibodies, cause reinfection’
  • Is reinfection of coronavirus a reality? Know if you are at risk
  • COVID-19 vaccines: How It Works, Who Should Take It, Safety, Precautions And Thereafter
  • Diabetic women under 55 at risk of heart disease; Know what to include in your diet
  • Breast cancer: Male sex hormones can effectively help in treating this condition

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.